| Tag | Content |
|---|
EnhancerAtlas ID | HS147-26911 |
Organism | Homo sapiens |
Tissue/cell | NHEK |
Coordinate | chr22:22203890-22205940 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Mecom | MA0029.1 | chr22:22205588-22205602 | AAGACAAGATAAAA | + | 7.52 | | Nr2f6(var.2) | MA0728.1 | chr22:22204592-22204607 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09367 | chr22:22203451-22205160 | CD14 | | SE_58780 | chr22:22161979-22223044 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I021849 | chr22 | 22204041 | 22204689 |
|
Enhancer Sequence | AATGATACCA AGTGTTGTTG AGAATATGCA CTGGTCTGAA CTCTAATACA CTGCTAATGG 60
AAATATTTTA CCACTTTGGA AAACAGTTTG GCACATCTAC TAAAATGGAA TCTATGCACA 120
GACTGACACA GTCATTCTGC TACTAAATAT ATACCCAGCA GGACAATGTG GCTCACGTCT 180
ATAATCAGCC CAGGCTGGTC TTGAACTCCT GAGCTCAAAG TGATCCTCTC ACCTTGGCTT 240
CCTAAAGTGT TGGGATTACA GGCATGAGCC ACCACATCTG GCCACTTTTC TTTATGTATA 300
TTATACATCA ATAAAAGTAA AGAATAAAAA GGGAGAAGAG TCTGAAAAGA ACAATTATCA 360
CAAAATTAAG GAACGTACTC AACTCTTAAA GATTTGAGAA GGCGTTTCTA AGGTACTAGC 420
AATGTTCCAT TTTGCAATCT GCACAGTGAT GACAAGTATT TAACTTATTC TGTAAACAGT 480
ACCTTTTTTT TTTTTTTTTT TGAGACAGAG TCTTGCTCTG TCGCCCAGGA TAGAGCACAG 540
TGGCGCGATC TCAGCTCACG GCAGCCTCTG CCTCCTGGGG TGACGTGATT CTCATGCCTC 600
AGCCTCTGGA GTAGCTAGGA TTACAGGCAG GCGCCACCAC GCCCAGCTAA TTTTTGTATT 660
TTTAGTAGAG ACAAGATTTT GCCATGTTGG CCAGGCTGGT CTTGAACTCC TGACCTCAAG 720
TGATCTGCCC GCCTTGGCCT TCCAAAGTGC TAGGATTACA GGCATGAGCC ACTGTGCCCA 780
GCCACAAACA GTACTTATAT CTTACCTATG TTTAAATGGA TATTCAAAAT AAGATTAAAA 840
GAGGTAAGAA AATACAATAC TCTAGTAAAT GTAAAAATAA GTGAGAAGAA TAAATGCCAA 900
GAGAAATATA ATTACCAAGA AGAAATTCAA AGTAGGAACA GTCGTATAAC CATTTTTAAA 960
ATAATTTTGA ATCAGCTTAA CATGTTTTCA ACAAAAAACC AAACACATAC CAAAACCAAA 1020
AAACCACCCA GGTCCAGACT TGTACAGGCA AGTTCTACCA AACTTTGAAG GAATCATTCT 1080
AATTTTACAG AAATAAAAAC AGAAGAATAG GAAAAGAAAC ACTTGCCAAT TCATTTTGTA 1140
AGGGTAGTCT AATTTTCATA CCAAACCACA TGAGAAAAAC CCTATTATTT ATTAACAAGC 1200
CAAATCCAGC AATATATAAT AATAATACAT CATGACCAAG TTGGGTTTAA TCCCAGGAAT 1260
GCAAAATTGA TTCAATATTA GAAAATCTAT TAGGGTAACA TGAAACTTAA AGAAAAAAAA 1320
CAAGAAAATT TCTATACATG CAATTAAAAA GCATCTGTAG AAATTCAATC ATTCAGGATT 1380
CTTTTTTTCT TTAAGTTTAA AAAAACTTGA CAAAGAAAGC TTTATGAAGC CAGGTGCTGT 1440
GGCATGTGCC TGTAATCCCA GCCATTCAGG AGGGTAAAGT GGGATGATCA CTTGAGCCCA 1500
GGAGTTTGAG ACCAGTCTGA GCAACATAGC AAGACCCTGT TTCCGGGGAG GGGGTGGGTG 1560
GGAAGTAAGC CTTATGAAAA ACCAGTAGCC CCTATCACTC AATAAAAGCT TTCCTTTTAA 1620
CATCAGAACA AGTCAGGGAT GCCCTCTGTA TCACCACTGC TCTTCAACTT TGTAATGGAG 1680
AGTCCGGCCA GCACAGTTAA GACAAGATAA AATATATCTA AGTCATGAAA AGAAACAAAA 1740
TATCATGATT TTCAGATGAT ATGTTTGTCC TTAAAAAATT TAAAGAGGGA TTACTGGAAT 1800
AAGAGTTTGT TGGACAATCT TTTTATTCCA GTAATTCATC AGTTTACAAA AGTCAAATGC 1860
ATTTCTATAA ACCATCTACA GATATCTCTT AGAATATAGC CGGGCATGGT GGTGGGCGCC 1920
TGTAATCCCA GCTACTAGGG AGGCTGAGGC AGGAGAATGG CGTGAACCCA GGAGGCGGAG 1980
CTTGCAATGA GCTGAGATCG CCACTGCACT CCAGCCTGGG CCACAGAGCG AGACTCTGTC 2040
TCAAAAAAAA 2050
|
